Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear
NCT00726245 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2011-07-12
Summary
the improvement of symptoms and disease progress by the treatment of OA of the knee with PRGF
Conditions
- Muscle Tear
Interventions
- BIOLOGICAL
-
PRGF
3-6mg IM (to area of muscle tear)
- BIOLOGICAL
-
3cc IM of physiological saline
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-01-31
- Primary Completion
- 2009-02-28
- Completion
- 2011-03-31
Countries
- Israel
Study Locations
More Related Trials
-
Role of Plasma Rich Growth Factor in Repair Primary Cleft Palate
NCT06889181 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sutureless Cryopreserved Amniotic Membrane Graft (ProKera) and Wound Healing After Photorefractive Keratectomy
NCT00915759 ·Status: COMPLETED ·Phase: NA
-
Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy
NCT04604834 ·Status: RECRUITING ·Phase: NA
-
Compare of PRP Autologous Serum and Autologous Serum by Intrastromal Injection in Different Eye Disease Conditions
NCT05944757 ·Status: UNKNOWN ·Phase: NA
-
Platelet-Rich Fibrin in the Healing of Regional and Free Flaps
NCT04023474 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Healing Properties on Corneal Cells of Groth Factor-enriched Plasma and Autologous Serum From Aniridia Patients
NCT05400590 ·Status: RECRUITING
-
PRP IN Planter Fascitis
NCT03938896 ·Status: UNKNOWN ·Phase: NA
-
Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases
NCT06200727 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma
NCT04252534 ·Status: COMPLETED ·Phase: NA
-
Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome
NCT04941807 ·Status: COMPLETED ·Phase: PHASE4
-
Percutaneous Needle Tenotomy (PNT) Versus Platelet Rich Plasma (PRP) With PNT in the Treatment of Chronic Tendinosis
NCT01833598 ·Status: COMPLETED ·Phase: NA
-
Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors
NCT06115005 ·Status: RECRUITING ·Phase: PHASE2
-
Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies
NCT00958802 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Levator Muscle Strength Evaluation
NCT02226016 ·Status: UNKNOWN ·Phase: NA
-
Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers
NCT05515731 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Amniotic Membrane and Platelet Rich Plasma Clot for Management of Central Corneal Perforation
NCT03500796 ·Status: COMPLETED ·Phase: NA
-
Treatment of Ligneous Conjunctivitis in Children With Plasminogen Deficiency
NCT05404932 ·Status: RECRUITING ·Phase: NA
-
Conjunctival Autologous Transplantation Using Fibrin Glue in Primary Pterygia
NCT00949728 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Topical Insuline in Corneal Epithelial Healing Post PRK
NCT06956846 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Treatment of PED With AMT and Autologous Serum
NCT00238862 ·Status: COMPLETED ·Phase: NA
-
Pterygium Head Body MMC1: Two Different Surgical Procedures and Their Effect on Endothelial Cell Count.
NCT02641132 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.
NCT01756456 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects
NCT03653650 ·Status: RECRUITING ·Phase: NA
-
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
NCT06261346 ·Status: RECRUITING ·Phase: NA
-
Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK)
NCT04283331 ·Status: UNKNOWN ·Phase: PHASE4